Sodium Alginate
Who holds supplier records for Sodium Alginate? 4 organisations hold a current record for Sodium Alginate: an active US FDA Type II Drug Master File or a CEP. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (2), Germany (1) and Norway (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Sodium Alginate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/sodium-alginate
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- No company-level GMP certificate matched
No current EU or UK GMP certificate was matched to these organisations. That is not a negative finding; ask each candidate for its certificate and latest inspection outcome.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Sodium Alginate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- GermanyCEP
- Qingdao Hyzlin Biology Development Co., Ltd.ChinaCEP
- ROQUETTE NORWAY ASNorwayCEPValid CEP holder (EDQM); not necessarily the manufacturer
- QINGDAO BRIGHT MOON SEAWEED GROUP CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Sodium Alginate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ROQUETTE NORWAY AS Vormedal | NO | CEP 2014-341 - Rev 03 Sodium alginate | Jun 2026 | — |
| QINGDAO BRIGHT MOON SEAWEED GROUP CO., LTD. Qingdao | CN | CEP 2023-334 - Rev 00 Sodium alginate | Jan 2025 | — |
| QINGDAO HYZLIN BIOLOGY DEVELOPMENT CO., LTD. Qingdao | CN | CEP 2023-182 - Rev 00 Sodium alginate | Dec 2024 | — |
| JRS Pharma GmbH & Co. KG. Rosenberg | DE | R1-CEP 2014-169 - Rev 00 Sodium alginate | Jun 2021 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Overview
Sodium Alginate is a unknown active pharmaceutical ingredient (ChEMBL CHEMBL2108744).
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Sodium Alginate?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Sodium Alginate: Jrs Pharma (Germany), Qingdao Hyzlin Biology Development Co., Ltd. (China), ROQUETTE NORWAY AS (Norway) and QINGDAO BRIGHT MOON SEAWEED GROUP CO., LTD. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Does Sodium Alginate have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Sodium Alginate on the EDQM register, including ROQUETTE NORWAY AS Vormedal (NO), QINGDAO BRIGHT MOON SEAWEED GROUP CO., LTD. Qingdao (CN), QINGDAO HYZLIN BIOLOGY DEVELOPMENT CO., LTD. Qingdao (CN) and JRS Pharma GmbH & Co. KG. Rosenberg (DE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Sodium Alginate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Sodium Alginate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.